A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction
Dengue virus causes approximately 96 million symptomatic infections annually, manifesting as dengue fever or occasionally as severe dengue1,2. There are no antiviral agents available to prevent or treat dengue. Here, we describe a highly potent dengue virus inhibitor (JNJ-A07) that exerts nanomolar...
Gespeichert in:
| Veröffentlicht in: | NATURE 2021-10, Vol.598 (7881), p.504-+ |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | + |
|---|---|
| container_issue | 7881 |
| container_start_page | 504 |
| container_title | NATURE |
| container_volume | 598 |
| creator | Kaptein, Suzanne J.F Goethals, Olivia Kiemel, Dominik Marchand, Arnaud Kesteleyn, Bart Bonfanti, Jean-Francois Bardiot, Dorothee Stoops, Bart Jonckers, Tim H.M Dallmeier, Kai Geluykens, Peggy Thys, Kim Crabbe, Marjolein Chatel-Chaix, Laurent Muenster, Max Querat, Gilles Touret, Franck de Lamballerie, Xavier Raboisson, Pierre Simmen, Kenny Chaltin, Patrick Bartenschlager, Ralf Van Loock, Marnix Neyts, Johan |
| description | Dengue virus causes approximately 96 million symptomatic infections annually, manifesting as dengue fever or occasionally as severe dengue1,2. There are no antiviral agents available to prevent or treat dengue. Here, we describe a highly potent dengue virus inhibitor (JNJ-A07) that exerts nanomolar to picomolar activity against a panel of 21 clinical isolates that represent the natural genetic diversity of known genotypes and serotypes. The molecule has a high barrier to resistance and prevents the formation of the viral replication complex by blocking the interaction between two viral proteins (NS3 and NS4B), thus revealing a previously undescribed mechanism of antiviral action. JNJ-A07 has a favourable pharmacokinetic profile that results in outstanding efficacy against dengue virus infection in mouse infection models. Delaying start of treatment until peak viraemia results in a rapid and significant reduction in viral load. An analogue is currently in further development. |
| format | Article |
| fullrecord | <record><control><sourceid>kuleuven</sourceid><recordid>TN_cdi_kuleuven_dspace_123456789_683277</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>123456789_683277</sourcerecordid><originalsourceid>FETCH-kuleuven_dspace_123456789_6832773</originalsourceid><addsrcrecordid>eNqVyrsOgjAUANAOmoiPf-jmYEgKBVpHNRomFt2bCleokkLaC9G_18EP0OksZ0ICxmIZMsmzGZl7f2eMpZFIApLvaK9t6MF1-OqBVmDrAeho3OCpsY25GuwcRe1qQGNrig3Q4szD4pzsPwHB6RJNZ5dketOth9XXBVmfjpdDHj6GFoYRrKp8r0tQUcyTNBNyqzLJYyH4P3Pz21T4RP4GOgZJhw</addsrcrecordid><sourcetype>Institutional Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction</title><source>Lirias (KU Leuven Association)</source><source>SpringerLink Journals</source><source>Nature</source><creator>Kaptein, Suzanne J.F ; Goethals, Olivia ; Kiemel, Dominik ; Marchand, Arnaud ; Kesteleyn, Bart ; Bonfanti, Jean-Francois ; Bardiot, Dorothee ; Stoops, Bart ; Jonckers, Tim H.M ; Dallmeier, Kai ; Geluykens, Peggy ; Thys, Kim ; Crabbe, Marjolein ; Chatel-Chaix, Laurent ; Muenster, Max ; Querat, Gilles ; Touret, Franck ; de Lamballerie, Xavier ; Raboisson, Pierre ; Simmen, Kenny ; Chaltin, Patrick ; Bartenschlager, Ralf ; Van Loock, Marnix ; Neyts, Johan</creator><creatorcontrib>Kaptein, Suzanne J.F ; Goethals, Olivia ; Kiemel, Dominik ; Marchand, Arnaud ; Kesteleyn, Bart ; Bonfanti, Jean-Francois ; Bardiot, Dorothee ; Stoops, Bart ; Jonckers, Tim H.M ; Dallmeier, Kai ; Geluykens, Peggy ; Thys, Kim ; Crabbe, Marjolein ; Chatel-Chaix, Laurent ; Muenster, Max ; Querat, Gilles ; Touret, Franck ; de Lamballerie, Xavier ; Raboisson, Pierre ; Simmen, Kenny ; Chaltin, Patrick ; Bartenschlager, Ralf ; Van Loock, Marnix ; Neyts, Johan</creatorcontrib><description>Dengue virus causes approximately 96 million symptomatic infections annually, manifesting as dengue fever or occasionally as severe dengue1,2. There are no antiviral agents available to prevent or treat dengue. Here, we describe a highly potent dengue virus inhibitor (JNJ-A07) that exerts nanomolar to picomolar activity against a panel of 21 clinical isolates that represent the natural genetic diversity of known genotypes and serotypes. The molecule has a high barrier to resistance and prevents the formation of the viral replication complex by blocking the interaction between two viral proteins (NS3 and NS4B), thus revealing a previously undescribed mechanism of antiviral action. JNJ-A07 has a favourable pharmacokinetic profile that results in outstanding efficacy against dengue virus infection in mouse infection models. Delaying start of treatment until peak viraemia results in a rapid and significant reduction in viral load. An analogue is currently in further development.</description><identifier>ISSN: 0028-0836</identifier><language>eng</language><publisher>NATURE PORTFOLIO</publisher><ispartof>NATURE, 2021-10, Vol.598 (7881), p.504-+</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,315,776,780,27837</link.rule.ids></links><search><creatorcontrib>Kaptein, Suzanne J.F</creatorcontrib><creatorcontrib>Goethals, Olivia</creatorcontrib><creatorcontrib>Kiemel, Dominik</creatorcontrib><creatorcontrib>Marchand, Arnaud</creatorcontrib><creatorcontrib>Kesteleyn, Bart</creatorcontrib><creatorcontrib>Bonfanti, Jean-Francois</creatorcontrib><creatorcontrib>Bardiot, Dorothee</creatorcontrib><creatorcontrib>Stoops, Bart</creatorcontrib><creatorcontrib>Jonckers, Tim H.M</creatorcontrib><creatorcontrib>Dallmeier, Kai</creatorcontrib><creatorcontrib>Geluykens, Peggy</creatorcontrib><creatorcontrib>Thys, Kim</creatorcontrib><creatorcontrib>Crabbe, Marjolein</creatorcontrib><creatorcontrib>Chatel-Chaix, Laurent</creatorcontrib><creatorcontrib>Muenster, Max</creatorcontrib><creatorcontrib>Querat, Gilles</creatorcontrib><creatorcontrib>Touret, Franck</creatorcontrib><creatorcontrib>de Lamballerie, Xavier</creatorcontrib><creatorcontrib>Raboisson, Pierre</creatorcontrib><creatorcontrib>Simmen, Kenny</creatorcontrib><creatorcontrib>Chaltin, Patrick</creatorcontrib><creatorcontrib>Bartenschlager, Ralf</creatorcontrib><creatorcontrib>Van Loock, Marnix</creatorcontrib><creatorcontrib>Neyts, Johan</creatorcontrib><title>A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction</title><title>NATURE</title><description>Dengue virus causes approximately 96 million symptomatic infections annually, manifesting as dengue fever or occasionally as severe dengue1,2. There are no antiviral agents available to prevent or treat dengue. Here, we describe a highly potent dengue virus inhibitor (JNJ-A07) that exerts nanomolar to picomolar activity against a panel of 21 clinical isolates that represent the natural genetic diversity of known genotypes and serotypes. The molecule has a high barrier to resistance and prevents the formation of the viral replication complex by blocking the interaction between two viral proteins (NS3 and NS4B), thus revealing a previously undescribed mechanism of antiviral action. JNJ-A07 has a favourable pharmacokinetic profile that results in outstanding efficacy against dengue virus infection in mouse infection models. Delaying start of treatment until peak viraemia results in a rapid and significant reduction in viral load. An analogue is currently in further development.</description><issn>0028-0836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>FZOIL</sourceid><recordid>eNqVyrsOgjAUANAOmoiPf-jmYEgKBVpHNRomFt2bCleokkLaC9G_18EP0OksZ0ICxmIZMsmzGZl7f2eMpZFIApLvaK9t6MF1-OqBVmDrAeho3OCpsY25GuwcRe1qQGNrig3Q4szD4pzsPwHB6RJNZ5dketOth9XXBVmfjpdDHj6GFoYRrKp8r0tQUcyTNBNyqzLJYyH4P3Pz21T4RP4GOgZJhw</recordid><startdate>20211021</startdate><enddate>20211021</enddate><creator>Kaptein, Suzanne J.F</creator><creator>Goethals, Olivia</creator><creator>Kiemel, Dominik</creator><creator>Marchand, Arnaud</creator><creator>Kesteleyn, Bart</creator><creator>Bonfanti, Jean-Francois</creator><creator>Bardiot, Dorothee</creator><creator>Stoops, Bart</creator><creator>Jonckers, Tim H.M</creator><creator>Dallmeier, Kai</creator><creator>Geluykens, Peggy</creator><creator>Thys, Kim</creator><creator>Crabbe, Marjolein</creator><creator>Chatel-Chaix, Laurent</creator><creator>Muenster, Max</creator><creator>Querat, Gilles</creator><creator>Touret, Franck</creator><creator>de Lamballerie, Xavier</creator><creator>Raboisson, Pierre</creator><creator>Simmen, Kenny</creator><creator>Chaltin, Patrick</creator><creator>Bartenschlager, Ralf</creator><creator>Van Loock, Marnix</creator><creator>Neyts, Johan</creator><general>NATURE PORTFOLIO</general><scope>FZOIL</scope></search><sort><creationdate>20211021</creationdate><title>A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction</title><author>Kaptein, Suzanne J.F ; Goethals, Olivia ; Kiemel, Dominik ; Marchand, Arnaud ; Kesteleyn, Bart ; Bonfanti, Jean-Francois ; Bardiot, Dorothee ; Stoops, Bart ; Jonckers, Tim H.M ; Dallmeier, Kai ; Geluykens, Peggy ; Thys, Kim ; Crabbe, Marjolein ; Chatel-Chaix, Laurent ; Muenster, Max ; Querat, Gilles ; Touret, Franck ; de Lamballerie, Xavier ; Raboisson, Pierre ; Simmen, Kenny ; Chaltin, Patrick ; Bartenschlager, Ralf ; Van Loock, Marnix ; Neyts, Johan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kuleuven_dspace_123456789_6832773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaptein, Suzanne J.F</creatorcontrib><creatorcontrib>Goethals, Olivia</creatorcontrib><creatorcontrib>Kiemel, Dominik</creatorcontrib><creatorcontrib>Marchand, Arnaud</creatorcontrib><creatorcontrib>Kesteleyn, Bart</creatorcontrib><creatorcontrib>Bonfanti, Jean-Francois</creatorcontrib><creatorcontrib>Bardiot, Dorothee</creatorcontrib><creatorcontrib>Stoops, Bart</creatorcontrib><creatorcontrib>Jonckers, Tim H.M</creatorcontrib><creatorcontrib>Dallmeier, Kai</creatorcontrib><creatorcontrib>Geluykens, Peggy</creatorcontrib><creatorcontrib>Thys, Kim</creatorcontrib><creatorcontrib>Crabbe, Marjolein</creatorcontrib><creatorcontrib>Chatel-Chaix, Laurent</creatorcontrib><creatorcontrib>Muenster, Max</creatorcontrib><creatorcontrib>Querat, Gilles</creatorcontrib><creatorcontrib>Touret, Franck</creatorcontrib><creatorcontrib>de Lamballerie, Xavier</creatorcontrib><creatorcontrib>Raboisson, Pierre</creatorcontrib><creatorcontrib>Simmen, Kenny</creatorcontrib><creatorcontrib>Chaltin, Patrick</creatorcontrib><creatorcontrib>Bartenschlager, Ralf</creatorcontrib><creatorcontrib>Van Loock, Marnix</creatorcontrib><creatorcontrib>Neyts, Johan</creatorcontrib><collection>Lirias (KU Leuven Association)</collection><jtitle>NATURE</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaptein, Suzanne J.F</au><au>Goethals, Olivia</au><au>Kiemel, Dominik</au><au>Marchand, Arnaud</au><au>Kesteleyn, Bart</au><au>Bonfanti, Jean-Francois</au><au>Bardiot, Dorothee</au><au>Stoops, Bart</au><au>Jonckers, Tim H.M</au><au>Dallmeier, Kai</au><au>Geluykens, Peggy</au><au>Thys, Kim</au><au>Crabbe, Marjolein</au><au>Chatel-Chaix, Laurent</au><au>Muenster, Max</au><au>Querat, Gilles</au><au>Touret, Franck</au><au>de Lamballerie, Xavier</au><au>Raboisson, Pierre</au><au>Simmen, Kenny</au><au>Chaltin, Patrick</au><au>Bartenschlager, Ralf</au><au>Van Loock, Marnix</au><au>Neyts, Johan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction</atitle><jtitle>NATURE</jtitle><date>2021-10-21</date><risdate>2021</risdate><volume>598</volume><issue>7881</issue><spage>504</spage><epage>+</epage><pages>504-+</pages><issn>0028-0836</issn><abstract>Dengue virus causes approximately 96 million symptomatic infections annually, manifesting as dengue fever or occasionally as severe dengue1,2. There are no antiviral agents available to prevent or treat dengue. Here, we describe a highly potent dengue virus inhibitor (JNJ-A07) that exerts nanomolar to picomolar activity against a panel of 21 clinical isolates that represent the natural genetic diversity of known genotypes and serotypes. The molecule has a high barrier to resistance and prevents the formation of the viral replication complex by blocking the interaction between two viral proteins (NS3 and NS4B), thus revealing a previously undescribed mechanism of antiviral action. JNJ-A07 has a favourable pharmacokinetic profile that results in outstanding efficacy against dengue virus infection in mouse infection models. Delaying start of treatment until peak viraemia results in a rapid and significant reduction in viral load. An analogue is currently in further development.</abstract><pub>NATURE PORTFOLIO</pub><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-0836 |
| ispartof | NATURE, 2021-10, Vol.598 (7881), p.504-+ |
| issn | 0028-0836 |
| language | eng |
| recordid | cdi_kuleuven_dspace_123456789_683277 |
| source | Lirias (KU Leuven Association); SpringerLink Journals; Nature |
| title | A pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A26%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kuleuven&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20pan-serotype%20dengue%20virus%20inhibitor%20targeting%20the%20NS3-NS4B%20interaction&rft.jtitle=NATURE&rft.au=Kaptein,%20Suzanne%20J.F&rft.date=2021-10-21&rft.volume=598&rft.issue=7881&rft.spage=504&rft.epage=+&rft.pages=504-+&rft.issn=0028-0836&rft_id=info:doi/&rft_dat=%3Ckuleuven%3E123456789_683277%3C/kuleuven%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |